Deleterious Variants of FIG4, a Phosphoinositide Phosphatase, in Patients with ALS
Name
Chow-2009-Deleterious Variants.pdf
Size
131.15 KB
Format
Adobe PDF
Checksum (MD5)
26829cda7fbf716cb416ac5c975b0bca
Author(s)
Chow, Clement Y.
Landers, John E.
Bergren, Sarah K.
Sapp, Peter C.
Grant, Adrienne E.
Jones, Julie M.
Everett, Lesley
Lenk, Guy M.
McKenna-Yasek, Diane M.
Weisman, Lois S.
Date Issued
January 2009
Journal
American Journal of Human Genetics
Publisher
Elsevier B.V.
Citation
Chow, Clement Y., John E. Landers, Sarah K. Bergren, Peter C. Sapp, Adrienne E. Grant, Julie M. Jones, Lesley Everett, et al. “Deleterious Variants of FIG4, a Phosphoinositide Phosphatase, in Patients with ALS.” The American Journal of Human Genetics 84, no. 1 (January 2009): 85–88.
Version
Final published version
Abstract
Mutations of the lipid phosphatase FIG4 that regulates PI(3,5)P2 are responsible for the recessive peripheral-nerve disorder CMT4J. We now describe nonsynonymous variants of FIG4 in 2% (9/473) of patients with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS). Heterozygosity for a deleterious allele of FIG4 appears to be a risk factor for ALS and PLS, extending the list of known ALS genes and increasing the clinical spectrum of FIG4-related diseases.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1016/j.ajhg.2008.12.010
